NAHL Group (NAH) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
12 Oct, 2026Opening remarks and agenda
Quorum confirmed; meeting formally opened after notice was sent to members on 30 May 2025.
Eight resolutions were scheduled: the first five ordinary, the final three special with a 75% approval threshold; online attendees could observe only.
Financial performance review
Q1 momentum continued into Q2; the board was confident of a full-year outturn in line with market expectations.
Corporate governance
Resolutions 1–4 covered the 2024 annual report and accounts, directors’ remuneration report, appointment of Forvis Mazars LLP through the next AGM, and auditor fee authority.
Resolutions 5–8 renewed share-allotment authority, cash allotment and pre-emption disapplications for specified purposes, and authority to purchase shares.
Partial view of Summaries dataset, powered by Quartr API
Latest events from NAHL Group
- Strong cash generation offset Personal Injury weakness as Critical Care grew.NAH
Trading update - Net debt fell 7%, Bush & Co. grew double digits, and full-year expectations were maintained.NAHTrading update
- FY25 profit and cash generation surged, but lower NAL enquiries cloud FY26.NAHTrading update
- Higher H1 profit and cash flow offset subdued case management in Critical Care.NAHTrading update
- Critical Care growth and lower debt cushioned Personal Injury market weakness.NAHH1 2024
- Underlying PBT more than doubled as Critical Care grew and net debt declined despite PI market headwinds.NAHH2 2024
- Profit and cash generation strengthened, cutting net debt to a 10-year low.NAHH1 2025
- FY2025 profit and cash surged, but lower settlements may constrain 2026 cash flow.NAHH2 2025
- Profit and cash grew in H1; settlement lifts guidance as net cash is targeted by end-October.NAHH1 2026